Study of men with inherited DNA repair mutations opens new therapeutic avenues in pro

[News]

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

More... (https://www.news-medical.net/news/20180209/Study-of-men-with-inherited-DNA-repair-mutations-opens-new-therapeutic-avenues-in-prostate-cancer.aspx)